Provided by Tiger Fintech (Singapore) Pte. Ltd.

Immunovant, Inc.

15.78
-0.6400-3.90%
Post-market: 15.780.00000.00%16:05 EDT
Volume:1.76M
Turnover:27.66M
Market Cap:2.68B
PE:-6.03
High:16.19
Open:15.85
Low:15.44
Close:16.42
Loading ...

Immunovant Is Maintained at Buy by B of A Securities

Dow Jones
·
15 Jan

Immunovant Inc : Bofa Global Research Cuts Price Objective to $45 From $48

THOMSON REUTERS
·
15 Jan

Analysts’ Top Healthcare Picks: Annexon Biosciences (ANNX), Immunovant (IMVT)

TIPRANKS
·
15 Jan

Immunovant Inc - to Sell 22.5 Mln Shares at $20 Each in Pipe

THOMSON REUTERS
·
13 Jan

Immunovant Announces $450 Million Private Placement

THOMSON REUTERS
·
13 Jan

Immunovant Announces $450 Million Private Placement

GlobeNewswire
·
13 Jan

Immunovant Cut to Peer Perform From Outperform by Wolfe Research

Dow Jones
·
03 Jan

Wolfe Research Downgrades Immunovant to Peer Perform From Outperform

MT Newswires Live
·
03 Jan

Immunovant downgraded to Peer Perform from Outperform at Wolfe Research

TIPRANKS
·
03 Jan

We Think Immunovant (NASDAQ:IMVT) Can Afford To Drive Business Growth

Simply Wall St.
·
30 Dec 2024

Immunovant price target lowered to $45 from $47 at Wells Fargo

TipRanks
·
20 Dec 2024

Why Is Immunovant, Inc. (IMVT) Among the Worst Performing Biotech Stocks in 2024?

Insider Monkey
·
22 Nov 2024

Q2 2024 Roivant Sciences Ltd Earnings Call

Thomson Reuters StreetEvents
·
13 Nov 2024

Immunovant's Q2 Loss Wider Than Expected, Pipeline in Focus

Zacks
·
08 Nov 2024

Immunovant Price Target Maintained With a $51.00/Share by HC Wainwright & Co.

Dow Jones
·
08 Nov 2024

Immunovant Inc reports results for the quarter ended in September 30 - Earnings Summary

Reuters
·
07 Nov 2024

Immunovant Fiscal Q2 Net Loss Widens

MT Newswires Live
·
07 Nov 2024

BRIEF-Immunovant Provides Development Updates And Reports Financial Results For The Quarter Ended September 30, 2024

Reuters
·
07 Nov 2024

Immunovant Q2 2025 GAAP EPS $(0.74) Misses $(0.60) Estimate, Cash Balance Of $472.9M

Benzinga
·
07 Nov 2024

Immunovant Provides Development Updates and Reports Financial Results for the Quarter Ended September 30, 2024

THOMSON REUTERS
·
07 Nov 2024